Stay updated on Zimmer Biomet with Becker's as they report on recent updates, including sales growth, a new acquisition, and a successful surgery.

Zimmer Biomet recently announced entering a definitive agreement to acquire all outstanding common shares of Paragon 28. Under the agreement, ...

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Q1 2025 Earnings Call Transcript February 12, 2025 NeuroOne Medical Technologies Corporation beats earnings expectations. Reported EPS is ...

Dave Rosa; President, Chief Executive Officer, Director; Neuroone Medical Technologies Corp. Ron McClurg; Chief Financial Officer; Neuroone Medical Technologies Corp ...

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025Management ViewCEO Dave Rosa highlighted the strong performance ...

Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenue from ...

Reports Q1 product revenue $3.3M vs. $1M last year. Reports Q1 license revenue $3M vs. $0 last year. “This quarter marks the next step forward ...

Q4 2024 Earnings Call Transcript February 6, 2025 Zimmer Biomet Holdings, Inc. beats earnings expectations. Reported EPS is ...

Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, ...

Zimmer Biomet (NYSE: ZBH) shares dipped slightly today on fourth-quarter results that came in just ahead of the consensus ...

Shares of Zimmer Biomet Holdings Inc. ZBH slipped 1.03% to $109.48 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.50% ...

Zimmer Biomet Holdings, Inc. ZBH is scheduled to report fourth-quarter 2024 results on Feb. 6, before market open. See the Zacks Earnings Calendar to stay ahead of market-making news. In the last ...